Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,707,199
+$145,465 QoQ
Shares Held
14,597
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#1,842
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compass Ion Advisors, LLC holds $14,145,503 across 9 Drug Manufacturers - General names. JNJ ranks #1 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
14,597 | $3,707,199 | |
| 2 | LLY |
ELI LILLY & Co
|
2,130 | $2,554,785 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,384 | $2,233,843 | |
| 4 | ABBV |
AbbVie Inc.
|
8,697 | $2,188,512 | |
| 5 | AMGN |
Amgen Inc
|
5,577 | $2,019,543 | |
| 6 | PFE |
Pfizer Inc
|
25,488 | $613,750 | |
| 7 | NVS |
Novartis AG
|
2,560 | $401,203 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,752 | $216,190 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,707,199 | 14,597 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $3,561,734 | 14,571 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,008,018 | 14,535 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,663,187 | 14,363 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,237,023 | 14,645 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,413,967 | 14,556 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,985,054 | 13,726 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,355,217 | 14,533 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,175,591 | 14,885 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,354,658 | 14,885 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,347,651 | 14,978 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,311,797 | 14,843 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $957,698 | 5,786 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $894,505 | 5,771 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $977,051 | 5,531 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $907,628 | 5,556 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $979,322 | 5,517 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $977,777 | 5,517 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $938,147 | 5,484 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $912,959 | 5,653 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,579,691 | 9,589 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,230,652 | 7,488 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,149,031 | 7,301 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,080,868 | 7,260 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $802,294 | 5,705 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $748,096 | 5,705 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||